Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Molecular and Cellular Biology
|
January 1, 1992
Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors
C M Rudin, U Storb
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 15, 2002
ONYX-015. Onyx Pharmaceuticals
E E Cohen, C M Rudin
Annual Review of Medicine
|
January 1, 1997
Apoptosis and disease: regulation and clinical relevance of programmed cell death
C M Rudin, C B Thompson
Genes, Chromosomes & Cancer
|
December 7, 2000
Transcriptional activation of short interspersed elements by DNA-damaging agents
C M Rudin, C B Thompson
Seminars in Oncology
|
September 5, 1998
B-cell development and maturation
C M Rudin, C B Thompson
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1990
Differential splicing of thymosin beta 4 mRNA
C M Rudin, P Engler, U Storb
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1991
Precursors of both conventional and Ly-1 B cells can escape feedback inhibition of Ig gene rearrangement
C M Rudin, J Hackett, U Storb
Oncogene
|
January 23, 1999
Signal transduction pathways that regulate cell survival and cell death
T Dragovich, C M Rudin, C B Thompson
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1991
Identification and localization of an enhancer for the human lambda L chain Ig gene complex
B B Blomberg, C M Rudin, U Storb
Traffic Injury Prevention
|
March 28, 2013
The impact of new legislation on child restraint system (CRS) misuse and inappropriate use in Australia
S Koppel, J L Charlton, C M Rudin-Brown
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Molecular and Cellular Biology
|
January 1, 1992
Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors
C M Rudin, U Storb
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 15, 2002
ONYX-015. Onyx Pharmaceuticals
E E Cohen, C M Rudin
Annual Review of Medicine
|
January 1, 1997
Apoptosis and disease: regulation and clinical relevance of programmed cell death
C M Rudin, C B Thompson
Genes, Chromosomes & Cancer
|
December 7, 2000
Transcriptional activation of short interspersed elements by DNA-damaging agents
C M Rudin, C B Thompson
Seminars in Oncology
|
September 5, 1998
B-cell development and maturation
C M Rudin, C B Thompson
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1990
Differential splicing of thymosin beta 4 mRNA
C M Rudin, P Engler, U Storb
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1991
Precursors of both conventional and Ly-1 B cells can escape feedback inhibition of Ig gene rearrangement
C M Rudin, J Hackett, U Storb
Oncogene
|
January 23, 1999
Signal transduction pathways that regulate cell survival and cell death
T Dragovich, C M Rudin, C B Thompson
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1991
Identification and localization of an enhancer for the human lambda L chain Ig gene complex
B B Blomberg, C M Rudin, U Storb
Traffic Injury Prevention
|
March 28, 2013
The impact of new legislation on child restraint system (CRS) misuse and inappropriate use in Australia
S Koppel, J L Charlton, C M Rudin-Brown
Page
of 5